# Study to Gather Information on the Kidney Function of Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem) Treated With Rivaroxaban or Vitamin K Antagonists

> **NCT04297072** · — · COMPLETED · sponsor: **Bayer** · enrollment: 25000 (actual)

## Conditions studied

- Non-Valvular Atrial Fibrillation

## Interventions

- **DRUG:** Rivaroxaban (Xarelto, BAY-597939)
- **DRUG:** VKAs

## Key facts

- **NCT ID:** NCT04297072
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-01
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-02-28
- **Target enrollment:** 25000 (ACTUAL)
- **Last updated:** 2021-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04297072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04297072, "Study to Gather Information on the Kidney Function of Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem) Treated With Rivaroxaban or Vitamin K Antagonists". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04297072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*